FDA OKs Nusinersen, First Drug for Spinal Muscular Atrophy – Medscape
Medscape FDA OKs Nusinersen, First Drug for Spinal Muscular AtrophyMedscapeThe US Food and Drug Administration (FDA) has approved nusinersen (Spinraza, Biogen and Ionis Pharmaceuticals), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease. SMA, which …Biogen gets FDA approval for first spinal muscular atrophy … Read more